Global Cancer Tumor Profiling Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Global Cancer Tumor Profiling Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Cancer Tumor Profiling Market Overview
1.1 Product Overview and Scope of Cancer Tumor Profiling
1.2 Classification of Cancer Tumor Profiling by Type
1.2.1 Global Cancer Tumor Profiling Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cancer Tumor Profiling Revenue Market Share by Type in 2019
1.2.3 Next-generation Sequencing (NGS)
1.2.4 Polymerase Chain Reaction (PCR)
1.2.5 Immunohistochemistry (IHC)
1.2.6 In Situ Hybridization (ISH)
1.2.7 Microarray
1.2.8 Others
1.3 Global Cancer Tumor Profiling Market by Application
1.3.1 Overview: Global Cancer Tumor Profiling Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Personalized Medicine
1.3.3 Diagnostics
1.3.4 Biomarker Discovery
1.3.5 Prognostics
1.3.6 Research Applications
1.4 Global Cancer Tumor Profiling Market by Regions
1.4.1 Global Cancer Tumor Profiling Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cancer Tumor Profiling (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cancer Tumor Profiling Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cancer Tumor Profiling Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Tumor Profiling Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cancer Tumor Profiling Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Tumor Profiling Status and Prospect (2015-2025)
2 Company Profiles
2.1 Qiagen N.V.
2.1.1 Qiagen N.V. Details
2.1.2 Qiagen N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Qiagen N.V. SWOT Analysis
2.1.4 Qiagen N.V. Product and Services
2.1.5 Qiagen N.V. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hologic Gen-Probe
2.2.1 Hologic Gen-Probe Details
2.2.2 Hologic Gen-Probe Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hologic Gen-Probe SWOT Analysis
2.2.4 Hologic Gen-Probe Product and Services
2.2.5 Hologic Gen-Probe Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.3 Illumina Inc.
2.3.1 Illumina Inc. Details
2.3.2 Illumina Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Illumina Inc. SWOT Analysis
2.3.4 Illumina Inc. Product and Services
2.3.5 Illumina Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche Molecular Systems Inc.
2.4.1 Roche Molecular Systems Inc. Details
2.4.2 Roche Molecular Systems Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche Molecular Systems Inc. SWOT Analysis
2.4.4 Roche Molecular Systems Inc. Product and Services
2.4.5 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.5 Genomic Health Inc.
2.5.1 Genomic Health Inc. Details
2.5.2 Genomic Health Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Genomic Health Inc. SWOT Analysis
2.5.4 Genomic Health Inc. Product and Services
2.5.5 Genomic Health Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abott Molecular
2.6.1 Abott Molecular Details
2.6.2 Abott Molecular Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abott Molecular SWOT Analysis
2.6.4 Abott Molecular Product and Services
2.6.5 Abott Molecular Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.7 Siemens Healthineers
2.7.1 Siemens Healthineers Details
2.7.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Siemens Healthineers SWOT Analysis
2.7.4 Siemens Healthineers Product and Services
2.7.5 Siemens Healthineers Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.8 HTG Molecular Diagnostic
2.8.1 HTG Molecular Diagnostic Details
2.8.2 HTG Molecular Diagnostic Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 HTG Molecular Diagnostic SWOT Analysis
2.8.4 HTG Molecular Diagnostic Product and Services
2.8.5 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.9 NeoGenomics Laboratories
2.9.1 NeoGenomics Laboratories Details
2.9.2 NeoGenomics Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 NeoGenomics Laboratories SWOT Analysis
2.9.4 NeoGenomics Laboratories Product and Services
2.9.5 NeoGenomics Laboratories Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.10 BD Biosciences
2.10.1 BD Biosciences Details
2.10.2 BD Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 BD Biosciences SWOT Analysis
2.10.4 BD Biosciences Product and Services
2.10.5 BD Biosciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.11 V., Strand
2.11.1 V., Strand Details
2.11.2 V., Strand Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 V., Strand SWOT Analysis
2.11.4 V., Strand Product and Services
2.11.5 V., Strand Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.12 Agendia
2.12.1 Agendia Details
2.12.2 Agendia Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Agendia SWOT Analysis
2.12.4 Agendia Product and Services
2.12.5 Agendia Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.13 Claris Life Sciences
2.13.1 Claris Life Sciences Details
2.13.2 Claris Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Claris Life Sciences SWOT Analysis
2.13.4 Claris Life Sciences Product and Services
2.13.5 Claris Life Sciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.14 ApoCell
2.14.1 ApoCell Details
2.14.2 ApoCell Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 ApoCell SWOT Analysis
2.14.4 ApoCell Product and Services
2.14.5 ApoCell Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.15 Foundation Medicine, Inc
2.15.1 Foundation Medicine, Inc Details
2.15.2 Foundation Medicine, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Foundation Medicine, Inc SWOT Analysis
2.15.4 Foundation Medicine, Inc Product and Services
2.15.5 Foundation Medicine, Inc Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.16 Personal Genome Diagnostics, Inc.
2.16.1 Personal Genome Diagnostics, Inc. Details
2.16.2 Personal Genome Diagnostics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Personal Genome Diagnostics, Inc. SWOT Analysis
2.16.4 Personal Genome Diagnostics, Inc. Product and Services
2.16.5 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.17 GenScript
2.17.1 GenScript Details
2.17.2 GenScript Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 GenScript SWOT Analysis
2.17.4 GenScript Product and Services
2.17.5 GenScript Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.18 Contextual Genomics
2.18.1 Contextual Genomics Details
2.18.2 Contextual Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Contextual Genomics SWOT Analysis
2.18.4 Contextual Genomics Product and Services
2.18.3 Contextual Genomics Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.19 Perthera, Inc.
2.19.1 Perthera, Inc. Details
2.19.2 Perthera, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Perthera, Inc. SWOT Analysis
2.19.4 Perthera, Inc. Product and Services
2.19.5 Perthera, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cancer Tumor Profiling Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Tumor Profiling Players Market Share
3.2.2 Top 10 Cancer Tumor Profiling Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cancer Tumor Profiling Revenue and Market Share by Regions
4.2 North America Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
4.3 Europe Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
4.5 South America Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
5 North America Cancer Tumor Profiling Revenue by Countries
5.1 North America Cancer Tumor Profiling Revenue by Countries (2015-2020)
5.2 USA Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
5.3 Canada Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
5.4 Mexico Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
6 Europe Cancer Tumor Profiling Revenue by Countries
6.1 Europe Cancer Tumor Profiling Revenue by Countries (2015-2020)
6.2 Germany Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
6.3 UK Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
6.4 France Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
6.5 Russia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
6.6 Italy Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cancer Tumor Profiling Revenue by Countries
7.1 Asia-Pacific Cancer Tumor Profiling Revenue by Countries (2015-2020)
7.2 China Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
7.3 Japan Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
7.4 Korea Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
7.5 India Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
8 South America Cancer Tumor Profiling Revenue by Countries
8.1 South America Cancer Tumor Profiling Revenue by Countries (2015-2020)
8.2 Brazil Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
8.3 Argentina Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cancer Tumor Profiling by Countries
9.1 Middle East & Africa Cancer Tumor Profiling Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
9.3 UAE Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
9.4 Egypt Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
9.5 South Africa Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cancer Tumor Profiling Revenue and Market Share by Type (2015-2020)
10.2 Global Cancer Tumor Profiling Market Forecast by Type (2019-2024)
10.3 Next-generation Sequencing (NGS) Revenue Growth Rate (2015-2025)
10.4 Polymerase Chain Reaction (PCR) Revenue Growth Rate (2015-2025)
10.5 Immunohistochemistry (IHC) Revenue Growth Rate (2015-2025)
10.6 In Situ Hybridization (ISH) Revenue Growth Rate (2015-2025)
10.7 Microarray Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Cancer Tumor Profiling Market Segment by Application
11.1 Global Cancer Tumor Profiling Revenue Market Share by Application (2015-2020)
11.2 Cancer Tumor Profiling Market Forecast by Application (2019-2024)
11.3 Personalized Medicine Revenue Growth (2015-2020)
11.4 Diagnostics Revenue Growth (2015-2020)
11.5 Biomarker Discovery Revenue Growth (2015-2020)
11.6 Prognostics Revenue Growth (2015-2020)
11.7 Research Applications Revenue Growth (2015-2020)
12 Global Cancer Tumor Profiling Market Size Forecast (2021-2025)
12.1 Global Cancer Tumor Profiling Market Size Forecast (2021-2025)
12.2 Global Cancer Tumor Profiling Market Forecast by Regions (2021-2025)
12.3 North America Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
12.4 Europe Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
12.6 South America Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Cancer Tumor Profiling Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Tumor Profiling by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Tumor Profiling Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cancer Tumor Profiling Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Qiagen N.V. Corporate Information, Location and Competitors
Table 6. Qiagen N.V. Cancer Tumor Profiling Major Business
Table 7. Qiagen N.V. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 8. Qiagen N.V. SWOT Analysis
Table 9. Qiagen N.V. Cancer Tumor Profiling Product and Solutions
Table 10. Qiagen N.V. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Hologic Gen-Probe Corporate Information, Location and Competitors
Table 12. Hologic Gen-Probe Cancer Tumor Profiling Major Business
Table 13. Hologic Gen-Probe Cancer Tumor Profiling Total Revenue (USD Million) (2018-2019)
Table 14. Hologic Gen-Probe SWOT Analysis
Table 15. Hologic Gen-Probe Cancer Tumor Profiling Product and Solutions
Table 16. Hologic Gen-Probe Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Illumina Inc. Corporate Information, Location and Competitors
Table 18. Illumina Inc. Cancer Tumor Profiling Major Business
Table 19. Illumina Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 20. Illumina Inc. SWOT Analysis
Table 21. Illumina Inc. Cancer Tumor Profiling Product and Solutions
Table 22. Illumina Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Molecular Systems Inc. Corporate Information, Location and Competitors
Table 24. Roche Molecular Systems Inc. Cancer Tumor Profiling Major Business
Table 25. Roche Molecular Systems Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 26. Roche Molecular Systems Inc. SWOT Analysis
Table 27. Roche Molecular Systems Inc. Cancer Tumor Profiling Product and Solutions
Table 28. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Genomic Health Inc. Corporate Information, Location and Competitors
Table 30. Genomic Health Inc. Cancer Tumor Profiling Major Business
Table 31. Genomic Health Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 32. Genomic Health Inc. SWOT Analysis
Table 33. Genomic Health Inc. Cancer Tumor Profiling Product and Solutions
Table 34. Genomic Health Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Abott Molecular Corporate Information, Location and Competitors
Table 36. Abott Molecular Cancer Tumor Profiling Major Business
Table 37. Abott Molecular Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 38. Abott Molecular SWOT Analysis
Table 39. Abott Molecular Cancer Tumor Profiling Product and Solutions
Table 40. Abott Molecular Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Siemens Healthineers Corporate Information, Location and Competitors
Table 42. Siemens Healthineers Cancer Tumor Profiling Major Business
Table 43. Siemens Healthineers Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 44. Siemens Healthineers SWOT Analysis
Table 45. Siemens Healthineers Cancer Tumor Profiling Product and Solutions
Table 46. Siemens Healthineers Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. HTG Molecular Diagnostic Corporate Information, Location and Competitors
Table 48. HTG Molecular Diagnostic Cancer Tumor Profiling Major Business
Table 49. HTG Molecular Diagnostic Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 50. HTG Molecular Diagnostic SWOT Analysis
Table 51. HTG Molecular Diagnostic Cancer Tumor Profiling Product and Solutions
Table 52. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. NeoGenomics Laboratories Corporate Information, Location and Competitors
Table 54. NeoGenomics Laboratories Cancer Tumor Profiling Major Business
Table 55. NeoGenomics Laboratories Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 56. NeoGenomics Laboratories SWOT Analysis
Table 57. NeoGenomics Laboratories Cancer Tumor Profiling Product and Solutions
Table 58. NeoGenomics Laboratories Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. BD Biosciences Corporate Information, Location and Competitors
Table 60. BD Biosciences Cancer Tumor Profiling Major Business
Table 61. BD Biosciences Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 62. BD Biosciences SWOT Analysis
Table 63. BD Biosciences Cancer Tumor Profiling Product and Solutions
Table 64. BD Biosciences Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. V., Strand Corporate Information, Location and Competitors
Table 66. V., Strand Cancer Tumor Profiling Major Business
Table 67. V., Strand Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 68. V., Strand SWOT Analysis
Table 69. V., Strand Cancer Tumor Profiling Product and Solutions
Table 70. V., Strand Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Agendia Corporate Information, Location and Competitors
Table 72. Agendia Cancer Tumor Profiling Major Business
Table 73. Agendia Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 74. Agendia SWOT Analysis
Table 75. Agendia Cancer Tumor Profiling Product and Solutions
Table 76. Agendia Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Claris Life Sciences Corporate Information, Location and Competitors
Table 78. Claris Life Sciences Cancer Tumor Profiling Major Business
Table 79. Claris Life Sciences Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 80. Claris Life Sciences SWOT Analysis
Table 81. Claris Life Sciences Cancer Tumor Profiling Product and Solutions
Table 82. Claris Life Sciences Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. ApoCell Corporate Information, Location and Competitors
Table 84. ApoCell Cancer Tumor Profiling Major Business
Table 85. ApoCell Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 86. ApoCell SWOT Analysis
Table 87. ApoCell Cancer Tumor Profiling Product and Solutions
Table 88. ApoCell Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Foundation Medicine, Inc Corporate Information, Location and Competitors
Table 90. Foundation Medicine, Inc Cancer Tumor Profiling Major Business
Table 91. Foundation Medicine, Inc Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 92. Foundation Medicine, Inc SWOT Analysis
Table 93. Foundation Medicine, Inc Cancer Tumor Profiling Product and Solutions
Table 94. Foundation Medicine, Inc Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Personal Genome Diagnostics, Inc. Corporate Information, Location and Competitors
Table 96. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Major Business
Table 97. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 98. Personal Genome Diagnostics, Inc. SWOT Analysis
Table 99. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product and Solutions
Table 100. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. GenScript Corporate Information, Location and Competitors
Table 102. GenScript Cancer Tumor Profiling Major Business
Table 103. GenScript Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 104. GenScript SWOT Analysis
Table 105. GenScript Cancer Tumor Profiling Product and Solutions
Table 106. GenScript Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Contextual Genomics Cancer Tumor Profiling Type and Application
Table 108. Contextual Genomics Cancer Tumor Profiling Major Business
Table 109. Contextual Genomics Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 110. Contextual Genomics SWOT Analysis
Table 111. Contextual Genomics Cancer Tumor Profiling Product and Solutions
Table 112. Contextual Genomics Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Perthera, Inc. Corporate Information, Location and Competitors
Table 114. Perthera, Inc. Cancer Tumor Profiling Major Business
Table 115. Perthera, Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 116. Perthera, Inc. SWOT Analysis
Table 117. Perthera, Inc. Cancer Tumor Profiling Product and Solutions
Table 118. Perthera, Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Global Cancer Tumor Profiling Revenue (Million USD) by Players (2015-2020)
Table 120. Global Cancer Tumor Profiling Revenue Share by Players (2015-2020)
Table 121. Global Cancer Tumor Profiling Revenue (Million USD) by Regions (2015-2020)
Table 122. Global Cancer Tumor Profiling Revenue Market Share by Regions (2015-2020)
Table 123. North America Cancer Tumor Profiling Revenue by Countries (2015-2020)
Table 124. North America Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Table 125. Europe Cancer Tumor Profiling Revenue (Million USD) by Countries (2015-2020)
Table 126. Asia-Pacific Cancer Tumor Profiling Revenue (Million USD) by Countries (2015-2020)
Table 127. South America Cancer Tumor Profiling Revenue by Countries (2015-2020)
Table 128. South America Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Table 129. Middle East and Africa Cancer Tumor Profiling Revenue (Million USD) by Countries (2015-2020)
Table 130. Middle East and Africa Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Table 131. Global Cancer Tumor Profiling Revenue (Million USD) by Type (2015-2020)
Table 132. Global Cancer Tumor Profiling Revenue Share by Type (2015-2020)
Table 133. Global Cancer Tumor Profiling Revenue Forecast by Type (2021-2025)
Table 134. Global Cancer Tumor Profiling Revenue by Application (2015-2020)
Table 135. Global Cancer Tumor Profiling Revenue Share by Application (2015-2020)
Table 136. Global Cancer Tumor Profiling Revenue Forecast by Application (2021-2025)
Table 137. Global Cancer Tumor Profiling Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Cancer Tumor Profiling Picture
Figure 2. Global Cancer Tumor Profiling Revenue Market Share by Type in 2019
Figure 3. Next-generation Sequencing (NGS) Picture
Figure 4. Polymerase Chain Reaction (PCR) Picture
Figure 5. Immunohistochemistry (IHC) Picture
Figure 6. In Situ Hybridization (ISH) Picture
Figure 7. Microarray Picture
Figure 8. Others Picture
Figure 9. Cancer Tumor Profiling Revenue Market Share by Application in 2019
Figure 10. Personalized Medicine Picture
Figure 11. Diagnostics Picture
Figure 12. Biomarker Discovery Picture
Figure 13. Prognostics Picture
Figure 14. Research Applications Picture
Figure 15. Global Cancer Tumor Profiling Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Cancer Tumor Profiling Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Cancer Tumor Profiling Revenue Market Share in 2019
Figure 24. Global Top 10 Players Cancer Tumor Profiling Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Cancer Tumor Profiling Revenue Market Share by Regions (2015-2020)
Figure 28. Global Cancer Tumor Profiling Revenue Market Share by Regions in 2018
Figure 29. North America Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 30. Europe Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 32. South America Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 34. North America Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure 35. North America Cancer Tumor Profiling Revenue Market Share by Countries in 2019
Figure 36. USA Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 37. Canada Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 39. Europe Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Cancer Tumor Profiling Revenue Market Share by Countries in 2019
Figure 41. Germany Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 42. UK Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 43. France Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 44. Russia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 45. Italy Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Cancer Tumor Profiling Revenue Market Share by Countries in 2019
Figure 48. China Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 49. Japan Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 50. Korea Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 51. India Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 53. South America Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure 54. South America Cancer Tumor Profiling Revenue Market Share by Countries in 2019
Figure 55. Brazil Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Cancer Tumor Profiling Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 60. UAE Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 63. Global Cancer Tumor Profiling Revenue Share by Type (2015-2020)
Figure 64. Global Cancer Tumor Profiling Revenue Share by Type in 2019
Figure 65. Global Cancer Tumor Profiling Market Share Forecast by Type (2021-2025)
Figure 66. Global Next-generation Sequencing (NGS) Revenue Growth Rate (2015-2020)
Figure 67. Global Polymerase Chain Reaction (PCR) Revenue Growth Rate (2015-2020)
Figure 68. Global Immunohistochemistry (IHC) Revenue Growth Rate (2015-2020)
Figure 69. Global In Situ Hybridization (ISH) Revenue Growth Rate (2015-2020)
Figure 70. Global Microarray Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Cancer Tumor Profiling Revenue Share by Application (2015-2020)
Figure 73. Global Cancer Tumor Profiling Revenue Share by Application in 2019
Figure 74. Global Cancer Tumor Profiling Market Share Forecast by Application (2021-2025)
Figure 75. Global Personalized Medicine Revenue Growth Rate (2015-2020)
Figure 76. Global Diagnostics Revenue Growth Rate (2015-2020)
Figure 77. Global Biomarker Discovery Revenue Growth Rate (2015-2020)
Figure 78. Global Prognostics Revenue Growth Rate (2015-2020)
Figure 79. Global Research Applications Revenue Growth Rate (2015-2020)
Figure 80. Global Cancer Tumor Profiling Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Cancer Tumor Profiling Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Cancer Tumor Profiling Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
Figure 84. Europe Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
Figure 86. South America Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs